Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

White Matter Lesion Progression: Genome-Wide Search for Genetic Influences.

Hofer E, Cavalieri M, Bis JC, DeCarli C, Fornage M, Sigurdsson S, Srikanth V, Trompet S, Verhaaren BF, Wolf C, Yang Q, Adams HH, Amouyel P, Beiser A, Buckley BM, Callisaya M, Chauhan G, de Craen AJ, Dufouil C, van Duijn CM, Ford I, Freudenberger P, Gottesman RF, Gudnason V, Heiss G, Hofman A, Lumley T, Martinez O, Mazoyer B, Moran C, Niessen WJ, Phan T, Psaty BM, Satizabal CL, Sattar N, Schilling S, Shibata DK, Slagboom PE, Smith A, Stott DJ, Taylor KD, Thomson R, Töglhofer AM, Tzourio C, van Buchem M, Wang J, Westendorp RG, Windham BG, Vernooij MW, Zijdenbos A, Beare R, Debette S, Ikram MA, Jukema JW, Launer LJ, Longstreth WT Jr, Mosley TH, Seshadri S, Schmidt H, Schmidt R; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium.

Stroke. 2015 Nov;46(11):3048-57. doi: 10.1161/STROKEAHA.115.009252. Epub 2015 Oct 8.

2.

A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Braskie MN, Thompson PM.

Biol Psychiatry. 2014 Apr 1;75(7):527-33. doi: 10.1016/j.biopsych.2013.11.020. Epub 2013 Nov 28. Review.

3.

Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.

Birdsill AC, Koscik RL, Jonaitis EM, Johnson SC, Okonkwo OC, Hermann BP, Larue A, Sager MA, Bendlin BB.

Neurobiol Aging. 2014 Apr;35(4):769-76. doi: 10.1016/j.neurobiolaging.2013.10.072. Epub 2013 Oct 10.

4.

APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, Wen W, Høgh P, Raz N, Au R, Beiser A, Wolf PA, Romero JR, Zhu YC, Lunetta KL, Farrer L, Dufouil C, Kuller LH, Mazoyer B, Seshadri S, Tzourio C, Debette S.

Neurology. 2013 Jul 16;81(3):292-300. doi: 10.1212/WNL.0b013e31829bfda4. Review.

5.

Multiple loci influencing hippocampal degeneration identified by genome scan.

Melville SA, Buros J, Parrado AR, Vardarajan B, Logue MW, Shen L, Risacher SL, Kim S, Jun G, DeCarli C, Lunetta KL, Baldwin CT, Saykin AJ, Farrer LA; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2012 Jul;72(1):65-75. doi: 10.1002/ana.23644. Epub 2012 Jun 28.

6.

Family history and APOE-4 genetic risk in Alzheimer's disease.

Donix M, Small GW, Bookheimer SY.

Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23. Review.

7.

Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people.

Donix M, Ercoli LM, Siddarth P, Brown JA, Martin-Harris L, Burggren AC, Miller KJ, Small GW, Bookheimer SY.

Am J Geriatr Psychiatry. 2012 Jul;20(7):565-73. doi: 10.1097/JGP.0b013e3182107e6a.

8.

Genetic architecture of declarative memory: implications for complex illnesses.

Bearden CE, Karlsgodt KH, Bachman P, van Erp TG, Winkler AM, Glahn DC.

Neuroscientist. 2012 Oct;18(5):516-32. Epub 2011 Aug 10. Review.

9.

Neuroimaging measures as endophenotypes in Alzheimer's disease.

Braskie MN, Ringman JM, Thompson PM.

Int J Alzheimers Dis. 2011 Mar 31;2011:490140. doi: 10.4061/2011/490140.

10.

Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Kalaria RN.

Nutr Rev. 2010 Dec;68 Suppl 2:S74-87. doi: 10.1111/j.1753-4887.2010.00352.x. Review.

11.

Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.

Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, Smith EE, Greenberg MS, Rosand J, Viswanathan A.

Neurology. 2010 Aug 24;75(8):693-8. doi: 10.1212/WNL.0b013e3181eee40f.

12.

Family history of Alzheimer's disease and hippocampal structure in healthy people.

Donix M, Burggren AC, Suthana NA, Siddarth P, Ekstrom AD, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Small GW, Bookheimer SY.

Am J Psychiatry. 2010 Nov;167(11):1399-406. doi: 10.1176/appi.ajp.2010.09111575. Epub 2010 Aug 4.

13.

Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease.

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group.

Neurology. 2010 Jul 13;75(2):137-42. doi: 10.1212/WNL.0b013e3181e7ca97.

14.

Bivariate heritability of total and regional brain volumes: the Framingham Study.

DeStefano AL, Seshadri S, Beiser A, Atwood LD, Massaro JM, Au R, Wolf PA, DeCarli C.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):218-23. doi: 10.1097/WAD.0b013e31819cadd8.

15.

Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer's disease: the MIRAGE study.

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA, Kurz A.

J Alzheimers Dis. 2009;17(4):855-62. doi: 10.3233/JAD-2009-1117.

16.

Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families.

Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA; MIRAGE Study Group.

Neurobiol Aging. 2011 Feb;32(2):249-56. doi: 10.1016/j.neurobiolaging.2009.02.014. Epub 2009 Mar 27.

17.

Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease.

T Cuenco K, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, Green RC, St George-Hyslop PH, Chui H, DeCarli C, Farrer LA; MIRAGE Study Group.

Arch Neurol. 2008 Dec;65(12):1640-8. doi: 10.1001/archneur.65.12.1640.

Supplemental Content

Support Center